Antimicrobial agent | No. (%) of susceptible isolate | p value | |
---|---|---|---|
non-ESBL-producing group N = 48 | ESBL producing groupN = 14 | ||
Ampicillin | 26 (54.2) | 1 (7.1) | 0.002 |
Ampicillin/sulbactam | 37 (77.1) | 4 (28.6) | 0.003 |
Piperacillin/tazobactam | 47 (97.9) | 12 (100) | 0.617 |
Aztreonam | 45 (95.7) | 8 (61.5) | 0.004 |
Cefoxitin | 42 (87.5) | 5 (41.7) | 0.002 |
Cefotaxim | 43 (89.6) | 3 (23.1) | <0.001 |
Ceftazidime | 46 (95.8) | 10 (71.4) | 0.02 |
Cefepime | 46 (95.8) | 4 (28.6) | <0.001 |
Meropenem | 44 (91.7) | 14 (100) | 0.297 |
Levofloxacin | 36 (75.0) | 6 (46.2) | 0.088 |
Amikacin | 47 (97.9) | 11 (78.6) | 0.033 |
Gentamicin | 34 (70.8) | 3 (21.4) | 0.001 |
Trimethoprim /sulfamethoxazole | 29 (60.4) | 4 (30.8) | 0.057+ |